You have 9 free searches left this month | for more free features.

active surveillance

Showing 26 - 50 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Reporting to Identify Adverse Events Following Chiropractic Care

Recruiting
  • Musculoskeletal Pain
  • Musculoskeletal Symptoms
  • Active Surveillance Reporting System
  • Toronto, Ontario, Canada
    Canadian Memorial Chiropractic College
Apr 22, 2022

Prostate Cancer Trial run by the National Cancer Institute (NCI) (mpMRI)

Recruiting
  • Prostate Cancer
  • mpMRI
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Aug 24, 2022

European Active Surveillance Study of LCS12

Recruiting
  • Contraception
    • Berlin, Germany
      Center for Epidemiology and Health Research Berlin
    Feb 23, 2022

    Active Surveillance in Prostate Cancer

    Completed
    • Prostate Cancer
    • Survey
    • Houston, Texas
      University of Texas MD Anderson Cancer Center
    Apr 1, 2022

    Prostatic Tumors Trial in Herlev (multiparametric MRI Diagnostics)

    Enrolling by invitation
    • Prostatic Neoplasms
    • multiparametric MRI Diagnostics
    • Herlev, Denmark
      Department of Urology, Herlev University Hospital Herlev
    Mar 25, 2022

    Prostatic Tumors, Prostate Cancer Trial (Vitamin D (Calcitriol))

    Withdrawn
    • Prostatic Neoplasms
    • Prostate Cancer
    • Vitamin D (Calcitriol)
    • (no location specified)
    Feb 14, 2022

    STHLM3 AS NorDCaP -Followup Study of Men on Active Surveillance

    Recruiting
    • Prostate Cancer
    • Stockholm3 test
    • Stockholm, Solna, Sweden
      Karolinska Institutet
    Mar 29, 2022

    Advanced Rectal Cancer Trial in Rochester (FOLFOX)

    Active, not recruiting
    • Advanced Rectal Cancer
    • Rochester, New York
    • +1 more
    Jun 9, 2022

    Nevoid Basal Cell Carcinomas in Gorlin Syndrome

    Enrolling by invitation
    • Basal Cell Carcinoma
    • Gorlin Syndrome
    • Active surveillance
    • Oslo, Norway
      Oslo University Hospital
    Jun 8, 2023

    Prostate Cancer Trial in Cleveland (virtual biopsy (VB) monitoring protocol)

    Withdrawn
    • Prostate Cancer
    • virtual biopsy (VB) monitoring protocol
    • Cleveland, Ohio
      University Hospitals Seidman Cancer Center, Case Comprehensive C
    May 16, 2022

    Bladder Cancer Trial in Barcelona (Endoscopic fulguration)

    Not yet recruiting
    • Bladder Cancer
    • Endoscopic fulguration
    • Barcelona, Spain
      Fernando Lozano Palacio
    Dec 7, 2021

    Diabetes, Diabetes, Type 2, Medullary Thyroid Carcinoma Trial in Morgantown (No treatment given)

    Enrolling by invitation
    • Diabetes
    • +3 more
    • No treatment given
    • Morgantown, West Virginia
      United BioSource, LLC
    Oct 4, 2022

    Rectal Adenocarcinoma, Stage II Rectal Cancer AJCC v8, Stage IIA Rectal Cancer AJCC v8 Trial in Houston (drug, other, procedure)

    Not yet recruiting
    • Rectal Adenocarcinoma
    • +8 more
    • Houston, Texas
      M D Anderson Cancer Center
    Feb 25, 2022

    Hepatitis Immune Trial (Active Surveillance, Early initiation)

    Not yet recruiting
    • Hepatitis Immune
    • Active Surveillance
    • Early initiation
    • (no location specified)
    Jul 14, 2022

    Prostate Adenocarcinoma, Prostate Cancer Trial in San Francisco (Hyperpolarized Carbon C 13 Pyruvate, Magnetic Resonance

    Recruiting
    • Prostate Adenocarcinoma
    • Prostate Cancer
    • Hyperpolarized Carbon C 13 Pyruvate
    • +2 more
    • San Francisco, California
      University of California, San Francisco
    Oct 3, 2022

    Prostate Cancer Trial (Apalutamide Oral Tablet [Erleada], Placebo)

    Not yet recruiting
    • Prostate Cancer
    • Apalutamide Oral Tablet [Erleada]
    • Placebo
    • (no location specified)
    Jan 11, 2022

    Prostate Cancer Trial in Dallas (Curcumin, Placebo)

    Recruiting
    • Prostate Cancer
    • Dallas, Texas
      UT Southwestern Medical Center
    Jan 25, 2022

    Prostate Active Surveillance Study

    Recruiting
    • Prostatic Neoplasms
      • San Francisco, California
      • +9 more
      Jul 5, 2022

      Assess Safety of Ozanimod in Moderate to Severe Active UC in

      Not yet recruiting
      • Ulcerative Colitis
      • Seoul, Korea, Republic of
        Bristol-Myers Squibb YH
      Oct 3, 2023

      Multiparametric MRI in Prostate Cancer Undergoing Active

      Enrolling by invitation
      • Prostatic Neoplasms
        • Herlev, Denmark
          Department of Urology, Herlev University Hospital Herlev
        Oct 15, 2021

        Solitary Pulmonary Nodule, Coin Lesion, Pulmonary, Lung Tumors Trial in Pasadena (More Frequent Surveillance Strategy, Less

        Active, not recruiting
        • Solitary Pulmonary Nodule
        • +3 more
        • More Frequent Surveillance Strategy
        • Less Frequent Surveillance Strategy
        • Pasadena, California
          Kaiser Permanente Southern California
        Sep 30, 2022

        Prostate Adenocarcinoma Trial in Seattle (Apalutamide, Laboratory Biomarker Analysis, Quality-of-Life Assessment)

        Terminated
        • Prostate Adenocarcinoma
        • Seattle, Washington
          Fred Hutch/University of Washington Cancer Consortium
        Dec 28, 2021

        Adenocarcinoma of the Prostate, Stage I Prostate Cancer, Stage IIA Prostate Cancer Trial in Los Angeles (behavioral, dietary

        Active, not recruiting
        • Adenocarcinoma of the Prostate
        • +3 more
        • behavioral dietary intervention
        • +2 more
        • Los Angeles, California
          Jonsson Comprehensive Cancer Center
        Apr 4, 2022

        Surveillance of Complex Renal Cysts - The SOCRATIC Study

        Recruiting
        • Complex Renal Cyst
        • Active surveillance
        • Surgery
        • Calgary, Alberta, Canada
        • +10 more
        Jan 3, 2023

        Prostate Cancer Trial (Lower-Carbohydrate Med-t-Diet, Low-Fat Med-t-Diet)

        Not yet recruiting
        • Prostate Cancer
        • Lower-Carbohydrate Med-t-Diet
        • Low-Fat Med-t-Diet
        • (no location specified)
        Dec 12, 2022